Abogenbio
abogenbio.com
Actively hiring
Financial Services
Health Care
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
Coatue, Qiming Venture Partners
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2019
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Coatue 
Qiming Venture Partners Similar startupsby what they do, their industry and backers
THE FIRST CELL-BASED mRNA THERAPEUTICS PLATFORM. Synthetic mRNA has reached its limits. Our cell-based mRNA design and manufacturing…
Elevated mRNA for transformative medicines. mRNA has already changed medicine. But the next generation of mRNA medicines – therapies that…
Gamgee is developing personalised mRNA vaccines as a cancer treatment for dogs, built from each dog’s tumour. See how it works with vets…
High-purity RNA for research and development. Cisterna Biologics offers custom RNA synthesis, including mRNA, with fast turnaround and…
We develop transformative mRNA therapies by leveraging our ground-breaking proprietary delivery technology, machine learning and superior…
ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our…
Overview
艾博生物成立于2019年1月，是一家专注于信使核糖核酸（mRNA）药物研发的临床期创新型生物医药公司，拥有业界领先并具有自主知识产权的mRNA和纳米递送技术平台。公司已建立了丰富的产品管线，涵盖传染病防治和肿瘤免疫等领域。.